1. Inactivation of HIV-1 Infection through Integrative Blocking with Amino phenylboronic acid Attributed Carbon Dots. Aung, Y.Y., A.N. Kristanti, S.Q. Khairunisa, N. Nasronudin, and M.Z. Fahmi. ACS Biomaterials Science & Engineering, 2020. 6(8): p. 4490-4501. ISI[000562119500015].
[WOS]. HIV_09_2020.
2. Ginkgolic acid Inhibits Fusion of Enveloped Viruses. Borenstein, R., B.A. Hanson, R.M. Markosyan, E.S. Gallo, S.D. Narasipura, M. Bhutta, O. Shechter, N.S. Lurain, F.S. Cohen, L. Al-Harthi, and D.A. Nicholson. Scientific Reports, 2020. 10(4746): 12pp. PMID[32179788]. PMCID[PMC7075884].
[PubMed]. HIV_09_2020.
3. Proteasomal Inhibition Potentiates Latent HIV Reactivation. Cary, D.C. and B.M. Peterlin. AIDS Research and Human Retroviruses, 2020. 36(10): p. 800-807. PMID[32683901].
[PubMed]. HIV_09_2020.
4. Bioisosterism-based Design and Enantiomeric Profiling of Chiral Hydroxyl-substituted Biphenyl-diarylpyrimidine Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors. Chen, X., L. Ding, Y. Tao, C. Pannecouque, E. de Clercq, C. Zhuang, and F.E. Chen. European Journal of Medicinal Chemistry, 2020. 202: 112549. PMID[32712537].
[PubMed]. HIV_09_2020.
5. Synthesis and Bioactivity of N-(4-Chlorophenyl)-4-methoxy-3-(methylamino) benzamide as a Potential anti-HBV Agent. Cui, A.L., W.F. Sun, Z.J. Zhong, J. Jin, S.T. Xue, S. Wu, Y.H. Li, and Z.R. Li. Drug Design Development and Therapy, 2020. 14: p. 3723-3729. PMID[32982177]. PMCID[PMC7501955].
[PubMed]. HIV_09_2020.
6. Single- and Repeated-dose Toxicity Studies on the Novel HIV Maturation Inhibitor QF-036 in Sprague-Dawley Rats. Cui, R.T., H.H. He, D.A. Yu, Z. Li, C.H. Jiang, D.F. Liu, T. Ou-Yang, N. Xie, and S.S. Yan. Toxicology Letters, 2020. 329: p. 26-30. PMID[32380124].
[PubMed]. HIV_09_2020.
7. Importance of Structure-based Studies for the Design of a Novel HIV-1 Inhibitor Peptide. Gomara, M.J., Y. Perez, P. Gomez-Gutierrez, C. Herrera, P. Ziprin, J.P. Martinez, A. Meyerhans, J.J. Perez, and I. Haro. Scientific Reports, 2020. 10(14430): 14pp. PMID[32879375]. PMCID[PMC7468280].
[PubMed]. HIV_09_2020.
8. Broadly Neutralizing Antibodies Combined with Latency-reversing Agents or Immune Modulators as Strategy for HIV-1 Remission. Gunst, J.D., J.F. Højen, and O.S. Søgaard. Current Opinion in HIV and Aids, 2020. 15(5): p. 309-315. PMID[32675575].
[PubMed]. HIV_09_2020.
9. Design, Synthesis and Biological Evaluation of Methylenehydrazine-1-carboxamide Derivatives with (5-((4-(Pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole Scaffold: Novel Potential CDK9 Inhibitors. Hu, H., J. Wu, M. Ao, X. Zhou, B. Li, Z. Cui, T. Wu, L. Wang, Y. Xue, Z. Wu, and M. Fang. Bioorganic Chemistry, 2020. 102: 104064. PMID[32653610].
[PubMed]. HIV_09_2020.
10. Alpha-Enolase in Viral Target Cells Suppresses the Human Immunodeficiency Virus Type 1 Integration. Kishimoto, N., K. Yamamoto, N. Iga, C. Kirihara, T. Abe, N. Takamune, and S. Misumi. Retrovirology, 2020. 17(1): p. 31. PMID[32917235]. PMCID[PMC7488571].
[PubMed]. HIV_09_2020.
11. Design, Synthesis and anti-HIV Evaluation of 5-Alkyl-6-(benzo[D][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as Potent HIV-1 NNRTIs. Li, Y.M., R.H. Luo, L.M. Yang, S.M. Huang, S.Y. Li, Y.G. Zheng, D.X. Ni, Y.M. Cui, X.J. Zhang, X.L. Li, R.H. Zhang, E. Tang, H.B. Zhang, Y.T. Zheng, Y.P. He, and W.L. Xiao. Bioorganic Chemistry, 2020. 102: 104041. PMID[32683184].
[PubMed]. HIV_09_2020.
12. Natural and Nature-inspired Stilbenoids as Antiviral Agents. Mattio, L.M., G. Catinella, A. Pinto, and S. Dallavalle. European Journal of Medicinal Chemistry, 2020. 202: 112541. PMID[32652408]. PMCID[PMC7335248].
[PubMed]. HIV_09_2020.
13. Nucleic acid Recognition and Antiviral Activity of 1,4-Substituted terphenyl Compounds Mimicking All Faces of the HIV-1 REV Protein Positively-charged Alpha-helix. Medina-Trillo, C., D.M. Sedgwick, L. Herrera, M. Beltran, A. Moreno, P. Barrio, L.M. Bedoya, J. Alcami, S. Fustero, and J. Gallego. Scientific Reports, 2020. 10(7190): 14pp. PMID[32346097]. PMCID[PMC7188855].
[PubMed]. HIV_09_2020.
14. Retinoic acid Improves the Recovery of Replication-competent Virus from Latent SIV Infected Cells. Olwenyi, O.A., A. Acharya, N.K. Routhu, K. Pierzchalski, J.W. Jones, M.A. Kane, N. Sidell, M. Mohan, and S.N. Byrareddy. Cells, 2020. 9(9): E2076. PMID[32932813].
[PubMed]. HIV_09_2020.
15. Protein Delivery of Cell-penetrating Zinc-finger Activators Stimulates Latent HIV-1-Infected Cells. Perdigao, P.R.L., C. Cunha-Santos, C.F. Barbas, M. Santa-Marta, and J. Goncalves. Molecular Therapy-Methods & Clinical Development, 2020. 18: p. 145-158. PMID[32637446]. PMCID[PMC7317221].
[PubMed]. HIV_09_2020.
16. Fingolimod Inhibits Multiple Stages of the HIV-1 Life Cycle. Resop, R.S., R. Fromentin, D. Newman, H. Rigsby, L. Dubrovsky, M. Bukrinsky, N. Chomont, and A. Bosque. Plos Pathogens, 2020. 16(8): e1008679. PMID[32790802]. PMCID[PMC7425850].
[PubMed]. HIV_09_2020.
17. Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals. Sampey, G.C., S. Iordanskiy, M.L. Pleet, C. DeMarino, F. Romerio, R. Mahieux, and F. Kashanchi. Viruses, 2020. 12(10): E1067. PMID[32977702].
[PubMed]. HIV_09_2020.
18. CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR. Sharma, A.L., J. Hokello, S. Sonti, S. Zicari, L. Sun, A. Alqatawni, M. Bukrinsky, G. Simon, A. Chauhan, R. Daniel, and M. Tyagi. Viruses, 2020. 12(9). PMID[32961937].
[PubMed]. HIV_09_2020.
19. Plant-based Production of Highly Potent anti-HIV Antibodies with Engineered Posttranslational Modifications. Singh, A.A., O. Pooe, L. Kwezi, T. Lotter-Stark, S.H. Stoychev, K. Alexandra, I. Gerber, J.N. Bhiman, J. Vorster, M. Pauly, L. Zeitlin, K. Whaley, L. Mach, H. Steinkellner, L. Morris, T.L. Tsekoa, and R. Chikwamba. Scientific Reports, 2020. 10(6201): 9pp. PMID[32277089]. PMCID[PMC7148297].
[PubMed]. HIV_09_2020.
20. Ethanolic Extract of Artemisia campestris Subsp. Glutinosa (Besser) Batt. Inhibits HIV-1 Replication in Vitro through the Activity of Terpenes and Flavonoids on Viral Entry and NF-kappa B Pathway. Ticona, L.A., P. Bermejo, J.A. Guerra, M.J. Abad, M. Beltran, R.M. Lazaro, J. Alcami, and L.M. Bedoya. Journal of Ethnopharmacology, 2020. 263. PMID[32758575]. PMCID[PMC7397943].
[PubMed]. HIV_09_2020.
Patent Citations
21. Forkhead Box Transcription Factor Foxo1a Inhibitor for Use in the Treatment of Latent Virus Infection. Mangeney, M., G. Bismuth, and A. Roux. Patent. 2020. 2020-EP54432 2020169707: 38pp.
[Patent]. HIV_09_2020.